Industri

What India and Africa can teach each other on animal he...

Animal health has become one of the defining priorities for agriculture across ...

OneSource Specialty Pharma and Formycon AG announce str...

OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formyco...

Why weight loss cannot be an aesthetic goal

How has the launch of GLP-1 medication disrupted weight loss/obesity care model...

Leiutis marks global milestone with CDSCO approval for ...

Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Contr...

Sun Pharma receives South Africa approval for generic s...

Company to launch once-weekly injectable for adults with type 2 diabetes in the...

Cleveland Clinic Advances Systemwide Growth With Main C...

Cleveland Clinic is moving forward on two major capital initiatives that undersc...

Bringing Modern Healthcare to a 19th Century City Building

Working with architectural firm HGA, the Massachusetts-based construction firm C...

CMS Proposes Medicare Outpatient Payment Update, New Po...

The Centers for Medicare & Medicaid Services (CMS) has proposed a broad package ...

Engaging Caregivers in the Design Process

For a healthcare organization kicking off a new building project, the beginning ...

Takeda and Indonesia partner on plasma-derived therapies

The Ministry of Health of the Republic of Indonesia (BKPM) has issued a fraction...

FDA approves MSD’s Keytruda combinations for MIBC

The new approvals for the anti-programmed death-1 (PD-1) therapies cover both ne...

New research using targeted gene technology to stop pso...

Professor Sulev Koks from the Personalised Medicine Centre has been awarded a N...

The GLP-1 effect: How weight-loss drugs could reshape I...

Everyone is talking about GLP-1 as the next big healthcare disruptor. That is o...

Melissa Kiefer Joins Suffolk Construction as Vice Presi...

Melissa Kiefer has joined Suffolk Construction as Vice President of Strategy, st...

Healthcare Lockers

Hollman Inc. now offers Healthcare Lockers, a dedicated product line built speci...

Teva and Polpharma Biologics sign global deal for ocrel...

Under the deal, Teva will hold exclusive rights to commercialise both intravenou...